메뉴 건너뛰기
Human Vaccines and Immunotherapeutics
Volumn 9, Issue 11, 2013, Pages 2427-2433
Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma
Author keywords

Long term survival; Mycobacterial vaccine; Stage IV melanoma
Indexed keywords

CANCER VACCINE; INTERLEUKIN 2; MYCOBACTERIUM VACCAE VACCINE; SRL 172; THALIDOMIDE; UNCLASSIFIED DRUG; INACTIVATED VACCINE;
EID: 84887415446     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25618     Document Type: Article
Times cited : (12)
References (23)
  • 1
    • 0034030469 scopus 로고    scopus 로고
    • Effective vaccination against tuberculosis - A new ray of hope
    • DOI 10.1046/j.1365-2249.2000.01145.x
    • Grange JM. Effective vaccination against tuber-culosis-a new ray of hope. Clin Exp Immunol 2000; 120: 232-4; PMID: 10792369; http://dx.doi.org/10.1046/j. 1365-2249.2000.01145.x (Pubitemid 30304215)
    • (2000) Clinical and Experimental Immunology , vol.120 , Issue.2 , pp. 232-234
    • Grange, J.M.1
  • 2
    • 0032812103 scopus 로고    scopus 로고
    • Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes
    • DOI 10.1023/A:1008307821189
    • Maraveyas A, Baban B, Kennard D, Rook GA, Westby M, Grange JM, et al. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleu-kin-2 in peripheral blood lymphocytes. Ann Oncol 1999; 10: 817-24; PMID: 10470429; http://dx.doi.org/10.1023/A: 1008307821189 (Pubitemid 29367999)
    • (1999) Annals of Oncology , vol.10 , Issue.7 , pp. 817-824
    • Maraveyas, A.1    Baban, B.2    Kennard, D.3    Rook, G.A.W.4    Westby, M.5    Grange, J.M.6    Lydyard, P.7    Stanford, J.L.8    Jones, M.9    Selby, P.10    Dalgleish, A.G.D.11
  • 3
    • 0031720653 scopus 로고    scopus 로고
    • Immunotherapy of advanced prostate cancer: A phase I/II trial using Mycobacterium vaccae (SRL172)
    • DOI 10.1046/j.1464-410X.1998.00803.x
    • Hrouda D, Baban B, Dunsmuir WD, Kirby RS, Dalgleish AG. Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172). Br J Urol 19 9 8; 8 2: 5 6 8-73; PMID: 9 8 0 619 0; http://dx.doi.org/10.1046/j.1464-410X.1998.00803.x (Pubitemid 28477302)
    • (1998) British Journal of Urology , vol.82 , Issue.4 , pp. 568-573
    • Hrouda, D.1
  • 4
    • 0041365767 scopus 로고    scopus 로고
    • A randomized phase II trial of SRL172 (Mycobacterium vaccae) ± low-dose interleukin-2 in the treatment of metastatic malignant melanoma
    • DOI 10.1097/00008390-200308000-00008
    • Nicholson SGK, Guile K, John J, Clarke IA, Diffey J, Donnellan P, et al. A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/-low-dose interleukin-2 in the treatment of meta-static malignant melanoma. Melanoma Res 2003; 13: 389-93; PMID: 12883365; http://dx.doi.org/10.1097/00008390-200308000- 00008 (Pubitemid 36900701)
    • (2003) Melanoma Research , vol.13 , Issue.4 , pp. 389-393
    • Nicholson, S.1    Guile, K.2    John, J.3    Clarke, I.A.4    Diffley, J.5    Donnellan, P.6    Michael, A.7    Szlosarek, P.8    Dalgleish, A.G.9
  • 5
    • 0036464024 scopus 로고    scopus 로고
    • A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy
    • PMID: 11899903
    • Assersohn L, Souberbielle BE, O'Brien ME, Archer CD, Mendes R, Bass R, et al. A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy. Clin Oncol (R Coll Radiol) 2002; 14: 23-7; PMID: 11899903; http://dx.doi.org/10.1053/clon.2001.0030
    • (2002) Clin Oncol (R Coll Radiol) , vol.14 , pp. 23-27
    • Assersohn, L.1    Souberbielle, B.E.2    O'Brien, M.E.3    Archer, C.D.4    Mendes, R.5    Bass, R.6
  • 6
    • 0033826267 scopus 로고    scopus 로고
    • A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma
    • PMID: 10970684
    • O'Brien ME, Saini A, Smith IE, Webb A, Gregory K, Mendes R, et al. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. Br J Cancer 2000; 83: 853-7; PMID: 10970684; http://dx.doi.org/ 10.1054/bjoc.2000.1401
    • (2000) Br J Cancer , vol.83 , pp. 853-857
    • O'Brien, M.E.1    Saini, A.2    Smith, I.E.3    Webb, A.4    Gregory, K.5    Mendes, R.6
  • 7
    • 82455172010 scopus 로고    scopus 로고
    • Therapeutic cancer vaccines: Why so few randomised phase III studies refect the initial optimism of phase II studies
    • PMID: 21933695
    • Dalgleish AG. Therapeutic cancer vaccines: why so few randomised phase III studies refect the initial optimism of phase II studies. Vaccine 2011; 29: 8501-5; PMID: 21933695; http://dx.doi.org/10.1016/j. vaccine.2011.09.012
    • (2011) Vaccine , vol.29 , pp. 8501-8505
    • Dalgleish, A.G.1
  • 8
    • 38149032470 scopus 로고    scopus 로고
    • Successful immunotherapy with Mycobacterium vac-cae in the treatment of adenocarcinoma of the lung
    • PMID: 17928219
    • Stanford JL, Stanford CA, O'Brien ME, Grange JM. Successful immunotherapy with Mycobacterium vac-cae in the treatment of adenocarcinoma of the lung. Eur J Cancer 2008; 44: 224-7; PMID: 17928219; http://dx.doi.org/10.1016/j.ejca.2007. 08.021
    • (2008) Eur J Cancer , vol.44 , pp. 224-227
    • Stanford, J.L.1    Stanford, C.A.2    O'Brien, M.E.3    Grange, J.M.4
  • 9
    • 38349048289 scopus 로고    scopus 로고
    • An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immu-notherapeutic agent in renal cancer
    • PMID: 1816 4612
    • Patel PM, Sim S, O'Donnell DO, Protheroe A, Beirne D, Stanley A, et al. An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immu-notherapeutic agent in renal cancer. Eur J Cancer 2008; 44: 216-23; PMID: 1816 4612; http://dx.doi.org/10.1016/j.ejca.2007.11.003
    • (2008) Eur J Cancer , vol.44 , pp. 216-223
    • Patel, P.M.1    Sim, S.2    O'Donnell, D.O.3    Protheroe, A.4    Beirne, D.5    Stanley, A.6
  • 10
    • 74949143594 scopus 로고    scopus 로고
    • Final version of 2009 AJCC melanoma staging and classifcation
    • PMID 19917835
    • Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classifcation. J Clin Oncol 2009; 27: 6199-206; PMID: 19917835; http://dx.doi.org/10.1200/JCO.2009.23.4799
    • (2009) J Clin Oncol , vol.27 , pp. 6199-6206
    • Balch, C.M.1    Gershenwald, J.E.2    Soong, S.J.3    Thompson, J.F.4    Atkins, M.B.5    Byrd, D.R.6
  • 11
    • 84887463835 scopus 로고    scopus 로고
    • Supernatant from tumour cells treated with chemotherapy stimulate professional antigen presenting cells in vitro
    • Fowler D, Liu WM, Smith P, Dalgleish AG. Supernatant from tumour cells treated with chemotherapy stimulate professional antigen presenting cells in vitro. Ejc Suppl 2009; 7: 115-6
    • (2009) Ejc Suppl , vol.7 , pp. 115-116
    • Fowler, D.1    Liu, W.M.2    Smith, P.3    Dalgleish, A.G.4
  • 12
    • 78249245421 scopus 로고    scopus 로고
    • Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania
    • PMID: 20875492
    • Lahey T, Arbeit RD, Bakari M, Horsburgh CR, Matee M, Waddell R, et al. Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. Vaccine 2010; 28: 7652-8; PMID: 20875492; http://dx.doi.org/10.1016/j.vaccine.2010.09.041
    • (2010) Vaccine , vol.28 , pp. 7652-7658
    • Lahey, T.1    Arbeit, R.D.2    Bakari, M.3    Horsburgh, C.R.4    Matee, M.5    Waddell, R.6
  • 13
    • 0034092903 scopus 로고    scopus 로고
    • Reduction in cytokine production in colorectal cancer patients: Association with stage and reversal by resection
    • Heriot AG, Marriott JB, Cookson S, Kumar D, Dalgleish AG. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer 2000; 82: 1009-12; PMID: 10737381; http://dx.doi.org/10.1054/bjoc.1999.1034 (Pubitemid 30128851)
    • (2000) British Journal of Cancer , vol.82 , Issue.5 , pp. 1009-1012
    • Heriot, A.G.1    Marriott, J.B.2    Cookson, S.3    Kumar, D.4    Dalgleish, A.G.5
  • 14
    • 33646849272 scopus 로고    scopus 로고
    • The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival
    • DOI 10.1038/sj.bjc.6603104, PII 6603104
    • Evans C, Morrison I, Heriot AG, Bartlett JB, Finlayson C, Dalgleish AG, et al. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their infuence upon survival. Br J Cancer 2006; 94: 1412-9; PMID: 16641913; http://dx.doi.org/10.1038/sj.bjc. 6603104 (Pubitemid 43772275)
    • (2006) British Journal of Cancer , vol.94 , Issue.10 , pp. 1412-1419
    • Evans, C.1    Morrison, I.2    Heriot, A.G.3    Bartlett, J.B.4    Finlayson, C.5    Dalgleish, A.G.6    Kumar, D.7
  • 15
    • 0036791943 scopus 로고    scopus 로고
    • The surgical management of metastatic melanoma
    • PMID: 12374659
    • Allen PJ, Coit DG. The surgical management of metastatic melanoma. Ann Surg Oncol 2002; 9: 762-70; PMID: 12374659; http://dx.doi.org/10.1007/BF02574 498
    • (2002) Ann Surg Oncol , vol.9 , pp. 762-770
    • Allen, P.J.1    Coit, D.G.2
  • 16
    • 34548249596 scopus 로고    scopus 로고
    • An International, ranodmized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites
    • MMAIT Clinical Trials Group
    • Morton DLMN, Thompson JF, Kelley MC, Faries M, Wagner J, Schneebaum S, et al., MMAIT Clinical Trials Group. An International, ranodmized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites. J Clin Oncol 2007; 25: 8508
    • (2007) J Clin Oncol , vol.25 , pp. 8508
    • Morton, D.L.M.N.1    Thompson, J.F.2    Kelley, M.C.3    Faries, M.4    Wagner, J.5    Schneebaum, S.6
  • 17
    • 59649112169 scopus 로고    scopus 로고
    • Surgery for melanoma metastases of the gastrointestinal tract: Indications and results
    • PMID: 18590949
    • Sanki A, Scolyer RA, Thompson JF. Surgery for melanoma metastases of the gastrointestinal tract: indications and results. Eur J Surg Oncol 2009; 35: 313-9; PMID: 18590949; http://dx.doi.org/10.1016/j. ejso.2008.04.011
    • (2009) Eur J Surg Oncol , vol.35 , pp. 313-319
    • Sanki, A.1    Scolyer, R.A.2    Thompson, J.F.3
  • 18
    • 79959975634 scopus 로고    scopus 로고
    • Does metas-tasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes
    • PMID: 21381040
    • Wasif N, Bagaria SP, Ray P, Morton DL. Does metas-tasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol 2011; 104: 111-5; PMID: 21381040; http://dx.doi.org/10. 1002/jso.21903
    • (2011) J Surg Oncol , vol.104 , pp. 111-115
    • Wasif, N.1    Bagaria, S.P.2    Ray, P.3    Morton, D.L.4
  • 19
    • 80052010199 scopus 로고    scopus 로고
    • Rationale for complete metastasectomy in patients with stage IV metastatic melanoma
    • PMID: 21858837
    • Ollila DW, Gleisner AL, Hsueh EC. Rationale for complete metastasectomy in patients with stage IV metastatic melanoma. J Surg Oncol 2011; 104: 420-4; PMID: 21858837; http://dx.doi.org/10.1002/js o. 219 61
    • (2011) J Surg Oncol , vol.104 , pp. 420-424
    • Ollila, D.W.1    Gleisner, A.L.2    Hsueh, E.C.3
  • 20
    • 84860491259 scopus 로고    scopus 로고
    • An intra-patient placebo-controlled phase i trial to evaluate the safety and tol-erability of intradermal IMM-101 in melanoma
    • PMID: 21930686
    • Stebbing J, Dalgleish A, Gifford-Moore A, Martin A, Gleeson C, Wilson G, et al. An intra-patient placebo-controlled phase I trial to evaluate the safety and tol-erability of intradermal IMM-101 in melanoma. Ann Oncol 2012; 23: 1314-9; PMID: 21930686; http://dx.doi.org/10.1093/annonc/mdr363
    • (2012) Ann Oncol , vol.23 , pp. 1314-1319
    • Stebbing, J.1    Dalgleish, A.2    Gifford-Moore, A.3    Martin, A.4    Gleeson, C.5    Wilson, G.6
  • 21
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • PMID: 20525992
    • Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23; PMID: 20525992; http://dx.doi.org/10.1056/NEJMoa1003466
    • (2010) N Engl J Med , vol.363 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3    Weber, R.W.4    Sosman, J.A.5    Haanen, J.B.6
  • 22
    • 79959772576 scopus 로고    scopus 로고
    • Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
    • PMID: 21639810
    • Robert C, Thomas L, Bondarenko I, O'Day S, M D JW, Garbe C, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011; 364: 2517-26; PMID: 21639810; http://dx.doi.org/10.1056/ NEJMoa1104621
    • (2011) N Engl J Med , vol.364 , pp. 2517-2526
    • Robert, C.1    Thomas, L.2    Bondarenko, I.3    O'Day, S.4    Garbe, C.5
  • 23
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • BRIM-3 Study Group PMID: 21639808
    • Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al.; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 36 4: 2507-16; PMID: 21639808; http://dx.doi.org/10.1056/NEJMoa1103782
    • (2011) N Engl J Med , vol.36 , Issue.4 , pp. 2507-2516
    • Chapman, P.B.1    Hauschild, A.2    Robert, C.3    Haanen, J.B.4    Ascierto, P.5    Larkin, J.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.